Taris Biomedical today announced positive results from the second arm of a study of its TAR-200 system for the treatment of patients with muscle-invasive bladder cancer (MIBC). The most recent study arm involved 10 patients treated with TAR-200 … Brooklin Models 1 43 Scale BRK39 001 - 1953 Oldsmobile Fiesta White bluee
| Condition: | New: A brand-new, unused, unopened, undamaged item (including handmade items). See the seller's ... Read moreabout the condition | Material: | disecaste |
| Brand: | eligor | Scale: | 1:43 |
Listen to the recording of Reed Tech’s ‘Blanket No Change Certification webinar’ to learn about annual No Change Certification submission requirements for drug product listings and what steps are … [Read More...]
Becton Dickinson (NYSE:BDX) recalled nearly 3,000 leaky SmartSite syringe administration sets used in the neonatal intensive care unit in what the FDA deemed a Class I action.Bespoke Model 1 43 Ferrari 375 TWS Goodwood 1952 Franklin Lakes, N.J.-based BD issued an urgent medical device recall in … [Read More...]
Livongo Health last week filed for an initial public offering worth $100 million for the digital health platform it developed to treat chronic diseases. The Mountain View, Calif.-based company's initial focus on diabetes involves a smart, … 2018Hot Wheels 2009 Nissan GT-R & Nissan Skyline Fast & Furious Fast five - 37
The U.S. Securities & Exchange Commission this week accused a coterie of lawyers of securities fraud in connection with nearly $1.7 million in illicit stock sales involving PixarBio. The scheme began in the fall of 2014, the SEC alleged, when … A.s.s Wiking Unverglast Tempo Matador Concrete Grey 1954 GK 340 4M CS 143 1N 1 wtop
Glaukos (NYSE:GKOS) said yesterday that closed the nearly $3 million plus milestones to acquire former subsidiary Dose Medical and its drug-delivery technology for treating retinal diseases. Sam Clemente, Calif.-based Glaukos spun Dose out as a … [Read More...]
Fresh off its $89.7 million jury award in a patent infringement case against GlaxoSmithKline (NYSE:GSK), British inhaler company Vectura has petitioned the court for an additional $44 million. Best 1 43 - Ferrari 250 LM tour from France 1969On May 16, a jury in U.S. District Court for the … [Read More...]
Apple (NSDQ:AAPL) is reportedly selling One Drop blood glucose monitors in a small number of its namesake stores in the U.S. One Drop is a compact blood glucose monitor that is compatible with the iOS Health app and the Apple Watch. The device is … AUDI 100 1970 polizei green 1 43 Minichamps 430019195 police allemande miniature
Taris Biomedical today announced positive results from the second arm of a study of its TAR-200 system for the treatment of patients with muscle-invasive bladder cancer (MIBC). The most recent study arm involved 10 patients treated with TAR-200 … [Read More...]
Medtronic (NYSE:MDT) today recalled two models of its MiniMed insulin pumps after researchers discovered cybersecurity risks that could allow a hacker to take control of the devices. Best of 1960s Muscle Cars Diecast - Set 5 Set of Three 1 24 Diecast Model CarsThe recall affects 11 models in Fridley, Minn.-based Medtronic's … [Read More...]
Pharmaceutical giant AbbVie (NYSE:ABBV) said today it will acquire Allergan (NYSE:AGN) for $63 billion in cash and stock. The purchase is seen as a hedge against the impending expiration of U.S. patents on AbbVie's blockbuster drug, Humira. AbbVie … [Read More...]
An FDA advisory panel on paclitaxel-eluting devices for treating peripheral artery disease yesterday found that the mortality signal indicated by a meta-analysis last year exists but that further study is needed to determine whether it's a class … Burago 1 18 scale Ferrari SF71H Sebastian Vettel 2018 18f1M
BIANTE 1 18 HOLDEN ZB COMMODORE COURTNEY MOBIL 1 BOOST 2018 ADELAIDE B18H18ETaris Biomedical today announced positive results from the second arm of a study of its TAR-200 system for the treatment of patients with muscle-invasive bladder cancer (MIBC). The most recent study arm involved 10 patients treated with TAR-200 and yielded positive safety, tolerability and preliminary efficacy data, according to Lexington, Mass.-based Taris. Combined data from […]
The American Diabetes Association’s 79th Scientific Sessions is a five-day conference where researchers and healthcare professionals share the latest in diabetes research. More than 180 sessions and over 2,000 research presentations took place during the meeting on June 7-11 in San Francisco. During the meeting, diabetes experts shared data and research from clinical trials. Here […]
Beta Bionics’ iLet bionic pancreas system significantly increased the percentage of time that adults with Type 1 diabetes spent with glucose levels between 70–180 mg/dl when compared to usual care therapy, according to a new study. The study’s results also suggest that the iLet, using either the Senseonics (NYSE:SENS) Eversense continuous glucose monitoring system (CGM) […]
Abbott (NYSE:ABT) said today that new data show its FreeStyle Libre continuous glucose monitoring (CGM) system significantly reduces hemoglobin A1c (HbA1c) levels in certain adults with type 2 diabetes. Presented as a late-breaker at American Diabetes Association (ADA) annual conference in San Francisco, the data represent what Abbott termed the first evaluation of real-world evidence from […]
Senseonics (NYSE:SENS) said yesterday that is presenting long-term safety data on its Eversense CGM from a European post-market clinical follow up registry later this week, touting that results showed the device as having a strong safety profile. The presentation is slated to take place this Saturday as part of the American Diabetes Association’s Scientific Sessions in […]
